TY - JOUR
T1 - Continuous cerebrovascular reactivity monitoring in moderate/severe traumatic brain injury: a narrative review of advances in neurocritical care
AU - Zeiler, F.A.
AU - Ercole, A.
AU - Czosnyka, M.
AU - Smielewski, P.
AU - Hawryluk, G.
AU - Hutchinson, P.J.A.
AU - Menon, D.K.
AU - Aries, M.
N1 - Funding Information:
University of Manitoba Thorlakson Chair for Surgical Research Establishment Grant, University of Manitoba VPRI Research Investment Fund (RIF) , Winnipeg Health Sciences Centre Foundation , and the University of Manitoba Rudy Falk Clinician–Scientist Professorship (to FAZ). NIHR (Research Professorship, Cambridge BRC and Global Health Research Group on Neurotrauma) (to PJH). National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre and a European Union Framework Program 7 grant ( CENTER-TBI ; Grant Agreement No. 602150 ).
Funding Information:
University of Manitoba Thorlakson Chair for Surgical Research Establishment Grant, University of Manitoba VPRI Research Investment Fund (RIF), Winnipeg Health Sciences Centre Foundation, and the University of Manitoba Rudy Falk Clinician?Scientist Professorship (to FAZ). NIHR (Research Professorship, Cambridge BRC and Global Health Research Group on Neurotrauma) (to PJH). National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre and a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).
Publisher Copyright:
© 2019 British Journal of Anaesthesia
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Impaired cerebrovascular reactivity in adult moderate and severe traumatic brain injury (TBI) is known to be associated with worse global outcome at 6-12 months. As technology has improved over the past decades, monitoring of cerebrovascular reactivity has shifted from intermittent measures, to experimentally validated continuously updating indices at the bedside. Such advances have led to the exploration of individualised physiologic targets in adult TBI management, such as optimal cerebral perfusion pressure (CPP) values, or CPP limits in which vascular reactivity is relatively intact. These targets have been shown to have a stronger association with outcome compared with existing consensus-based guideline thresholds in severe TBI care. This has sparked ongoing prospective trials of such personalised medicine approaches in adult TBI. In this narrative review paper, we focus on the concept of cerebral autoregulation, proposed mechanisms of control and methods of continuous monitoring used in TBI. We highlight multimodal cranial monitoring approaches for continuous cerebrovascular reactivity assessment, physiologic and neuroimaging correlates, and associations with outcome. Finally, we explore the recent 'state-of-the-art' advances in personalised physiologic targets based on continuous cerebrovascular reactivity monitoring, their benefits, and implications for future avenues of research in TBI.
AB - Impaired cerebrovascular reactivity in adult moderate and severe traumatic brain injury (TBI) is known to be associated with worse global outcome at 6-12 months. As technology has improved over the past decades, monitoring of cerebrovascular reactivity has shifted from intermittent measures, to experimentally validated continuously updating indices at the bedside. Such advances have led to the exploration of individualised physiologic targets in adult TBI management, such as optimal cerebral perfusion pressure (CPP) values, or CPP limits in which vascular reactivity is relatively intact. These targets have been shown to have a stronger association with outcome compared with existing consensus-based guideline thresholds in severe TBI care. This has sparked ongoing prospective trials of such personalised medicine approaches in adult TBI. In this narrative review paper, we focus on the concept of cerebral autoregulation, proposed mechanisms of control and methods of continuous monitoring used in TBI. We highlight multimodal cranial monitoring approaches for continuous cerebrovascular reactivity assessment, physiologic and neuroimaging correlates, and associations with outcome. Finally, we explore the recent 'state-of-the-art' advances in personalised physiologic targets based on continuous cerebrovascular reactivity monitoring, their benefits, and implications for future avenues of research in TBI.
KW - autoregulation measurement techniques
KW - blood-flow autoregulation
KW - cerebral autoregulation
KW - cerebral perfusion-pressure
KW - cerebrovascular reactivity
KW - intracranial-pressure
KW - lower limit
KW - neurocritical care
KW - plateau waves
KW - single nucleotide polymorphisms
KW - spreading depression
KW - tissue oxygen
KW - traumatic brain injury
KW - BLOOD-FLOW AUTOREGULATION
KW - TISSUE OXYGEN
KW - CEREBROVASCULAR REACTIVITY
KW - PLATEAU WAVES
KW - CEREBRAL PERFUSION-PRESSURE
KW - SPREADING DEPRESSION
KW - LOWER LIMIT
KW - AUTOREGULATION MEASUREMENT TECHNIQUES
KW - INTRACRANIAL-PRESSURE
KW - SINGLE NUCLEOTIDE POLYMORPHISMS
U2 - 10.1016/j.bja.2019.11.031
DO - 10.1016/j.bja.2019.11.031
M3 - (Systematic) Review article
C2 - 31983411
SN - 0007-0912
VL - 124
SP - 440
EP - 453
JO - British Journal of Anaesthesia
JF - British Journal of Anaesthesia
IS - 4
ER -